An angiotensin-converting enzyme 2 (ACE2) upregulation in active IBD tissue has been linked to compensatory anti-inflammatory responses (discussed in [32]) but may also result in increased SARS-CoV-2 vulnerability in people with gastrointestinal infections. The gene discussed is ACE2; the disease is inflammatory bowel disease.